<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="cyclic-n" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">cyclic-n</book-part-id>
      <title-group>
        <title>
<italic toggle="yes">ELANE</italic>-Related Neutropenia</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Dale</surname>
            <given-names>David C</given-names>
          </name>
          <degrees>MD</degrees>
          <email>dcdale@u.washington.edu</email>
          <aff>Professor, Department of Medicine<break/>University of Washington Medical Center<break/>Seattle, Washington</aff>
        </contrib>
      </contrib-group>
      <pub-history>
        <date iso-8601-date="2002-06-17" date-type="created">
          <day>17</day>
          <month>6</month>
          <year>2002</year>
        </date>
        <date iso-8601-date="2011-07-14" date-type="updated">
          <day>14</day>
          <month>7</month>
          <year>2011</year>
        </date>
        <date iso-8601-date="2009-07-07" date-type="revised">
          <day>7</day>
          <month>7</month>
          <year>2009</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="efemp2-cutis-laxa" document-type="chapter">
<italic toggle="yes">EFEMP2</italic>-Related Cutis Laxa</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="epb42-spherocytosis" document-type="chapter"><italic toggle="yes">EPB42</italic>-Related Hereditary Spherocytosis</related-object>
      <abstract id="cyclic-n.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p><italic toggle="yes">ELANE</italic>-related neutropenia includes congenital neutropenia and cyclic neutropenia, both of which are primary hematologic disorders characterized by recurrent fever, skin and oropharyngeal inflammation (i.e., mouth ulcers, gingivitis, sinusitis, and pharyngitis), and cervical adenopathy. Infectious complications are generally more severe in congenital neutropenia than in cyclic neutropenia.</p>
          <p>In congenital neutropenia, omphalitis immediately after birth may be the first sign; in untreated children diarrhea, pneumonia, and deep abscesses in the liver, lungs, and subcutaneous tissues are common in the first year of life. After 15 years with granulocyte colony stimulating factor treatment, the risk of developing myelodysplasia (MDS) or acute myelogenous leukemia AML is approximately 15%-25%.</p>
          <p>Cyclic neutropenia is usually diagnosed within the first year of life based on approximately three-week intervals of fever and oral ulcerations and regular oscillations of blood cell counts. Cellulitis, especially perianal cellulitis, is common during neutropenic periods. Between neutropenic periods, affected individuals are generally healthy. Symptoms improve in adulthood. Cyclic neutropenia is not associated with risk of malignancy or conversion to leukemia.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of <italic toggle="yes">ELANE</italic>-related neutropenia relies primarily on serial measurements of the absolute neutrophil count (ANC) and clinical findings. <italic toggle="yes">ELANE</italic> is the only gene in which mutation is known to cause <italic toggle="yes">ELANE</italic>-related neutropenia. For individuals with well-documented cyclic neutropenia and known affected family members, the mutation detection rate is as high as 100%. For individuals with congenital neutropenia, the mutation detection rate is as high as 80%.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> All fevers and infections require prompt evaluation and treatment. Abdominal pain requires evaluation for the potentially lethal complications of peritonitis and bacteremia. </p>
          <p><italic toggle="yes">Prevention of primary manifestations:</italic> Treatment with granulocyte colony-stimulating factor (G-CSF) ameliorates symptoms and reduces infections in almost all affected individuals. For affected individuals with a well-matched donor, hematopoietic stem cell transplantation (HSCT) may be the preferred treatment option. HSCT is the only alternative therapy for individuals with congenital neutropenia who are refractory to high-dose G-CSF or who undergo malignant transformation. </p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> Good dental hygiene.</p>
          <p><italic toggle="yes">Surveillance:</italic> Those with congenital neutropenia not undergoing HSCT require surveillance for malignant transformation to MDS/AML. </p>
          <p><italic toggle="yes">Evaluation of relatives at risk:</italic> Evaluation of at-risk relatives can help identify those with mild or moderately severe disease who may benefit from treatment. If the family-specific <italic toggle="yes">ELANE</italic> mutation is known, molecular genetic testing can be used; otherwise serial absolute neutrophil counts (ANCs) can be evaluated.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p><italic toggle="yes">ELANE</italic>-related neutropenia is inherited in an autosomal dominant manner. One parent of a proband is usually affected. <italic toggle="yes">De novo</italic> mutations have been identified; their frequency is unknown. Each child of an individual with an <italic toggle="yes">ELANE</italic> pathogenic variant has a 50% chance of inheriting the variant. Prenatal testing is possible for pregnancies at increased risk if the family-specific pathogenic variant is known; however, requests for prenatal testing for conditions such as <italic toggle="yes">ELANE</italic>-related neutropenia which do not affect intellect and have some treatment available are not common.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="cyclic-n.GeneReview_Scope">
        <title><italic toggle="yes">GeneReview</italic> Scope</title>
        <table-wrap id="cyclic-n.Tc" position="anchor" orientation="portrait">
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_cyclic-n.Tc_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1"><italic toggle="yes">ELANE</italic>-Related Neutropenia: Included Disorders&#x000a0;<sup>1</sup></th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_cyclic-n.Tc_1_1_1_1" valign="top" align="left" rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>Congenital neutropenia</p>
                    </list-item>
                    <list-item>
                      <p>Cyclic neutropenia </p>
                    </list-item>
                  </list>
                </td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>For synonyms and outdated names see <xref ref-type="sec" rid="cyclic-n.Nomenclature">Nomenclature</xref>.</p>
            </fn>
            <fn id="cyclic-n.TF.c.1">
              <label>1. </label>
              <p>Forms of these disorders associated with genes other than <italic toggle="yes">ELANE</italic> are not addressed in this <italic toggle="yes">GeneReview</italic>.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="cyclic-n.Diagnosis">
        <title>Diagnosis</title>
        <sec id="cyclic-n.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p><italic toggle="yes">ELANE</italic>-related neutropenia includes congenital neutropenia and cyclic neutropenia. Congenital neutropenia and cyclic neutropenia were initially thought to be distinct disorders; however, following discovery of the molecular basis of <italic toggle="yes">ELANE</italic>-related neutropenia, individuals with findings intermediate between these two phenotypes are also recognized. Nonetheless, identification of the phenotype is helpful for diagnosis, prognosis, and management.</p>
          <p>Diagnosis of congenital neutropenia or cyclic neutropenia is based on serial absolute neutrophil counts (ANCs) and clinical findings, including the following:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Congenital neutropenia.</bold> Recurrent fevers, sinusitis, gingivitis, and chronic and severe infections in the lung, liver, and soft tissues occurring at irregular intervals</p>
            </list-item>
            <list-item>
              <p><bold>Cyclic neutropenia.</bold> Typically, mouth ulcers, pharyngitis, and fever recurring regularly at three-week intervals; inflammation and infection of the sinuses, upper- and lower-respiratory tract, and skin including the perianal area; abdominal pain and signs of an acute abdomen, suggesting sepsis and bacteremia from colonic ulcers</p>
            </list-item>
          </list>
          <p>Note: Cyclic neutropenia is distinguished from congenital neutropenia by the regular oscillations of blood neutrophil counts in cyclic neutropenia.</p>
        </sec>
        <sec id="cyclic-n.Testing">
          <title>Testing</title>
          <p>
            <bold>Congenital neutropenia</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Absolute neutrophil count (ANC).</bold> Diagnosis requires at least three ANCs lower than 500/&#x000b5;L obtained at least three months after birth. Note: (1) The ANC is the white blood cell count (WBC) x % neutrophils. (2) In <italic toggle="yes">ELANE</italic>-related congenital neutropenia, ANCs are usually below 0.2 x 10<sup>9</sup>/L. (3) In one series, the mean was 0.112 x 10<sup>9</sup>/L.</p>
            </list-item>
            <list-item>
              <p><bold>Oscillations.</bold> In some individuals, periods with regular oscillations in blood neutrophil counts can be interspersed with periods in which no oscillations in blood neutrophil counts are apparent.Note: Often, serial blood cell counts are needed to assure that individuals suspected of having congenital neutropenia do not have cyclic neutropenia; however, this approach has limitations because, in some cases of cyclic neutropenia, the amplitude of the oscillations may be very low.</p>
            </list-item>
            <list-item>
              <p>
                <bold>Other hematopoietic cells</bold>
              </p>
              <list list-type="bullet">
                <list-item>
                  <p>Monocyte counts tend to be increased (i.e., &#x0003e;1.0 x 10<sup>9</sup>/L).</p>
                </list-item>
                <list-item>
                  <p>Platelet counts tend to be increased.</p>
                </list-item>
                <list-item>
                  <p>Hematocrit tends to be mildly decreased.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p><bold>Bone marrow aspirate</bold> typically shows "maturation arrest" at the promyelocyte or myelocyte stage of neutrophil formation. Increased bone marrow monocytes and eosinophils may be present.</p>
            </list-item>
            <list-item>
              <p><bold>Cytogenetic analysis</bold> of bone marrow is normal.</p>
            </list-item>
          </list>
          <p>
            <bold>Cyclic neutropenia</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Absolute neutrophil count (ANC).</bold> Diagnosis requires serial measurements of the ANC daily or at least three times per week for four to six weeks [<xref ref-type="bibr" rid="cyclic-n.REF.dale.2001">Dale 2001</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Oscillations.</bold> Most affected individuals have an ANC lower than 0.2 x 10<sup>9</sup>/L for three to five days at approximately three-week intervals.Note: (1) In <italic toggle="yes">ELANE</italic>-related cyclic neutropenia, peak neutrophil counts are usually lower than 0.2 x 10<sup>9</sup>/L. (2) Variations in this classic pattern include cycles longer or shorter than three weeks (probably &#x0003c;5% of individuals) and reduced amplitude of oscillations. (3) Relatives of individuals with typical cycles may have neutropenia but lack obvious cycles. (4) Counts in children tend to oscillate more obviously than in adults.</p>
            </list-item>
            <list-item>
              <p>
                <bold>Other hematopoietic cells</bold>
              </p>
              <list list-type="bullet">
                <list-item>
                  <p>Oscillations of other cells, including lymphocytes, eosinophils, and platelets may be observed.</p>
                </list-item>
                <list-item>
                  <p>Usually, a reciprocal increase in blood monocytes and reticulocytes occurs during the neutrophil nadir.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p><bold>Bone marrow aspirate</bold> shows an abnormality similar to that in congenital neutropenia when neutrophil counts are the lowest; at other times, maturation of cells of the neutrophil lineage is near normal.</p>
            </list-item>
          </list>
          <sec id="cyclic-n.Molecular_Genetic_Testing">
            <title>Molecular Genetic Testing</title>
            <p><bold>Gene.</bold>
<italic toggle="yes">ELANE</italic> (previously known as <italic toggle="yes">ELA2</italic>) is the only gene in which mutation is known to cause <italic toggle="yes">ELANE</italic>-related neutropenia.</p>
            <p>
              <bold>Clinical testing</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p><bold>Sequence analysis</bold><bold>Cyclic neutropenia.</bold> Pathogenic variants in <italic toggle="yes">ELANE</italic> were initially reported in 100% of individuals with well-documented cyclic neutropenia [<xref ref-type="bibr" rid="cyclic-n.REF.horwitz.1999.433">Horwitz et al 1999</xref>, <xref ref-type="bibr" rid="cyclic-n.REF.dale.2000.2317">Dale et al 2000</xref>]. Subsequently, <italic toggle="yes">ELANE</italic> pathogenic variants were found in 94 of 105 (90%) of a more diverse population with a clinical diagnosis of cyclic neutropenia; i.e., diagnosis based on clinical history and a limited number of serial neutrophil counts [<xref ref-type="bibr" rid="cyclic-n.REF.aprikyan.2002">Aprikyan et al 2002</xref>]. Further experience indicates that most individuals with a clinical diagnosis of cyclic neutropenia in whom a pathogenic variant in <italic toggle="yes">ELANE</italic> is not found are atypical in some way; i.e., oscillations are not consistently at the usual interval of approximately 21 days, the fluctuations are not from near zero at the nadir to less than approximately 2.0 x 10<sup>9</sup>/L at the peak, or serial neutrophil count data are insufficient to be certain about oscillations and fluctuations<bold>.<break/><break/>Congenital neutropenia.</bold> Mutation of <italic toggle="yes">ELANE</italic> was initially reported in 88% of individuals with congenital neutropenia [<xref ref-type="bibr" rid="cyclic-n.REF.dale.2000.2317">Dale et al 2000</xref>]. Further studies showed that 38%-80% of individuals with congenital neutropenia have heterozygous pathogenic variants [<xref ref-type="bibr" rid="cyclic-n.REF.aprikyan.2002">Aprikyan et al 2002</xref>, <xref ref-type="bibr" rid="cyclic-n.REF.ancliff.2003b.165">Ancliff et al 2003b</xref>, <xref ref-type="bibr" rid="cyclic-n.REF.bellann_chantelot.2004.4119">Bellann&#x000e9;-Chantelot et al 2004</xref>]; this broad range probably depends on the selectivity of the pre-test assessments.</p>
              </list-item>
            </list>
            <table-wrap id="cyclic-n.T.summary_of_molecular_genetic" position="anchor" orientation="portrait">
              <label>Table 1. </label>
              <caption>
                <p>Summary of Molecular Genetic Testing Used in <italic toggle="yes">ELANE</italic>-Related Neutropenia</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_cyclic-n.T.summary_of_molecular_genetic_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_cyclic-n.T.summary_of_molecular_genetic_1_1_1_1">Gene&#x000a0;<sup>1</sup></th>
                    <th id="hd_h_cyclic-n.T.summary_of_molecular_genetic_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_cyclic-n.T.summary_of_molecular_genetic_1_1_1_2">Test Method</th>
                    <th id="hd_h_cyclic-n.T.summary_of_molecular_genetic_1_1_1_3" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_cyclic-n.T.summary_of_molecular_genetic_1_1_1_3">Mutations Detected&#x000a0;<sup>2</sup></th>
                    <th id="hd_h_cyclic-n.T.summary_of_molecular_genetic_1_1_1_4" colspan="2" valign="top" align="left" scope="colgroup" rowspan="1">Mutation Detection Frequency by Test Method and Phenotype&#x000a0;<sup>3</sup></th>
                  </tr>
                  <tr>
                    <th headers="hd_h_cyclic-n.T.summary_of_molecular_genetic_1_1_1_4" id="hd_h_cyclic-n.T.summary_of_molecular_genetic_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Cyclic Neutropenia</th>
                    <th headers="hd_h_cyclic-n.T.summary_of_molecular_genetic_1_1_1_4" id="hd_h_cyclic-n.T.summary_of_molecular_genetic_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Congenital Neutropenia</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_cyclic-n.T.summary_of_molecular_genetic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                      <italic toggle="yes">ELANE</italic>
                    </td>
                    <td headers="hd_h_cyclic-n.T.summary_of_molecular_genetic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4</sup></td>
                    <td headers="hd_h_cyclic-n.T.summary_of_molecular_genetic_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                    <td headers="hd_h_cyclic-n.T.summary_of_molecular_genetic_1_1_1_4 hd_h_cyclic-n.T.summary_of_molecular_genetic_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">90%-100%&#x000a0;<sup>5</sup></td>
                    <td headers="hd_h_cyclic-n.T.summary_of_molecular_genetic_1_1_1_4 hd_h_cyclic-n.T.summary_of_molecular_genetic_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">38%-80%&#x000a0;<sup>5</sup></td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="cyclic-n.TF.1.1">
                  <label>1. </label>
                  <p>See <related-object source-id="gene" document-id="cyclic-n" object-id="cyclic-n.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein. </p>
                </fn>
                <fn id="cyclic-n.TF.1.2">
                  <label>2. </label>
                  <p>See <xref ref-type="sec" rid="cyclic-n.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants. </p>
                </fn>
                <fn id="cyclic-n.TF.1.3">
                  <label>3. </label>
                  <p>The ability of the test method used to detect a mutation that is present in the indicated gene </p>
                </fn>
                <fn id="cyclic-n.TF.1.4">
                  <label>4. </label>
                  <p>Examples of variants detected by sequence analysis may include small intragenic deletions/insertions and missense, nonsense, and splice site mutations; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>. </p>
                </fn>
                <fn id="cyclic-n.TF.1.5">
                  <label>5. </label>
                  <p><xref ref-type="bibr" rid="cyclic-n.REF.aprikyan.2002">Aprikyan et al [2002]</xref>, <xref ref-type="bibr" rid="cyclic-n.REF.ancliff.2003b.165">Ancliff et al [2003b]</xref>, <xref ref-type="bibr" rid="cyclic-n.REF.bellann_chantelot.2004.4119">Bellann&#x000e9;-Chantelot et al [2004]</xref></p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Interpretation of test results.</bold> Individuals thought to have congenital neutropenia who do not have an <italic toggle="yes">ELANE</italic> pathogenic variant may have pathogenic variants in other genes associated with abnormalities of immune or autoimmune mechanisms (see <xref ref-type="sec" rid="cyclic-n.Differential_Diagnosis">Differential Diagnosis</xref>). </p>
            <p>Mutation of more than one gene associated with neutropenia has been identified in some individuals [<xref ref-type="bibr" rid="cyclic-n.REF.germeshausen.2010.1207">Germeshausen et al 2010</xref>]. </p>
          </sec>
        </sec>
        <sec id="cyclic-n.Testing_Strategy">
          <title>Testing Strategy</title>
          <p>
            <bold>To confirm/establish the diagnosis in a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Diagnosis of congenital neutropenia and cyclic neutropenia depends on ANC obtained over specific time intervals.</p>
            </list-item>
            <list-item>
              <p>Bone marrow examination is often helpful to confirm the diagnosis of congenital neutropenia and cyclic neutropenia and to rule out other disorders such as myelodysplasia or leukemia.</p>
            </list-item>
            <list-item>
              <p>The finding of an <italic toggle="yes">ELANE</italic> pathogenic variant in an individual with neutropenia establishes the diagnosis of <italic toggle="yes">ELANE</italic>-related neutropenia.</p>
            </list-item>
          </list>
          <p><bold>Prenatal diagnosis and preimplantation genetic diagnosis (PGD)</bold> for at-risk pregnancies require prior identification of the pathogenic variant in the family.</p>
        </sec>
      </sec>
      <sec id="cyclic-n.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="cyclic-n.Clinical_Description">
          <title>Clinical Description</title>
          <p><bold>Congenital neutropenia.</bold> Infectious complications are generally more severe in congenital neutropenia than in cyclic neutropenia. In both conditions, individuals have fever and recurrent skin and oropharyngeal inflammation (i.e., mouth ulcers, gingivitis, sinusitis, pharyngitis, and cervical adenopathy). In congenital neutropenia, diarrhea, pneumonia, and deep abscesses in the liver, lung, and subcutaneous tissues are common. Omphalitis immediately after birth may be the first sign [<xref ref-type="bibr" rid="cyclic-n.REF.zeidler.2002.82">Zeidler &#x00026; Welte 2002</xref>]. Bacteremia occurs infrequently but has severe consequences in affected individuals. Most congenital neutropenia is diagnosed because of fever and severe infection in infants and young children.</p>
          <p>Treatment with granulocyte colony-stimulating factor (G-CSF) raises blood neutrophil levels and reduces all of these complications in more than 90% of affected individuals [<xref ref-type="bibr" rid="cyclic-n.REF.zeidler.2002.82">Zeidler &#x00026; Welte 2002</xref>, <xref ref-type="bibr" rid="cyclic-n.REF.dale.2003.82">Dale et al 2003</xref>].</p>
          <p>Individuals with congenital neutropenia with or without an <italic toggle="yes">ELANE</italic> pathogenic variant who are treated with G-CSF have approximately equal risk for myelodysplasia syndrome (MDS)/acute myelogenous leukemia (AML). The respective cumulative incidences 15 years after starting treatment with G-CSF were 36% and 25% (<italic toggle="yes">P</italic> = 0.96) [<xref ref-type="bibr" rid="cyclic-n.REF.rosenberg.2006.4628">Rosenberg et al 2006</xref>, <xref ref-type="bibr" rid="cyclic-n.REF.rosenberg.2008.210">Rosenberg et al 2008</xref>].</p>
          <p>MDS/AML was reported in individuals with severe congenital neutropenia before the availability of G-CSF treatment. Data from a prospective study of 374 persons with severe congenital neutropenia on long-term treatment with G-CSF showed that the overall risk of MDS/AML was 15%-25% at 15 years on treatment. Overall, G-CSF reduced mortality from sepsis, but uncovered an underlying disposition to MDS/AML. Individuals requiring higher doses of G-CSF, i.e., those requiring more than 8 &#x000b5;g/kg/day to achieve a mean neutrophil count equal to the group median (2.188 x 10<sup>9</sup>/L), were at increased risk of death from both sepsis and MDS/AML, compared to those responding to lower doses [<xref ref-type="bibr" rid="cyclic-n.REF.rosenberg.2010.196">Rosenberg et al 2010</xref>]. </p>
          <p><bold>Cyclic neutropenia.</bold> Cyclic neutropenia is usually diagnosed soon after birth or within the first year of life based on a pattern of recurrent fever and oral ulcerations with serial blood cell counts showing regular oscillations.</p>
          <p>Untreated individuals have recurrent oropharyngeal inflammation; they are particularly prone to developing oral ulcers at approximately three-week intervals. Cellulitis, especially perianal cellulitis, is common during the neutropenic periods. Bacteremia is rare; the greatest risk appears to be for death from necrotizing enterocolitis, peritonitis, and <italic toggle="yes">Clostridium</italic> and/or <italic toggle="yes">E. coli</italic> sepsis [<xref ref-type="bibr" rid="cyclic-n.REF.barnes.2004.e757">Barnes et al 2004</xref>].</p>
          <p>Symptoms tend to be more severe in children than in adults. <xref ref-type="bibr" rid="cyclic-n.REF.palmer.1996.413">Palmer et al [1996]</xref> reported that more than 60% of individuals with cyclic neutropenia experience oral ulcerations, gingivitis, lymphadenopathy, fever, pharyngitis/tonsillitis, fatigue, or skin infections five or more times a year. More than 30% of adults report five or more episodes per year of sinusitis and/or otitis media, and over 20% of children report at least five episodes per year of bone pain or tooth abscesses. More than 10% of individuals report pneumonia, bronchitis, diarrhea, or anal ulcers. Serious neonatal infections and sepsis are rare.</p>
          <p>Between neutropenic periods, affected individuals are generally healthy.</p>
          <p>Symptoms improve in adulthood. Skin infections, fever, lymphadenopathy, and pharyngitis occur less frequently. Sinusitis, headache, and bone pain remain the most common symptoms. Oral ulcers, fatigue, and gingivitis also occur frequently. Permanent tooth loss resulting from chronic gingivitis, tooth abscesses, and alveolar bone loss in adolescence or young adulthood is common.</p>
          <p>There are no associated congenital abnormalities. Cyclic phenomena in other organ systems have not been recognized.</p>
          <p>Cyclic neutropenia is not associated with an increased risk of malignancy or conversion to leukemia. However, confusion may arise when the series of counts is insufficient to clearly determine if a patient has congenital or cyclic neutropenia [<xref ref-type="bibr" rid="cyclic-n.REF.dale.2000.2317">Dale et al 2000</xref>, <xref ref-type="bibr" rid="cyclic-n.REF.dale.2003.82">Dale et al 2003</xref>].</p>
        </sec>
        <sec id="cyclic-n.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Genotype-phenotype correlations are only roughly defined for <italic toggle="yes">ELANE</italic>-related neutropenia. Although the patterns of pathogenic variants in <italic toggle="yes">ELANE</italic>-associated cyclic neutropenia and congenital neutropenia are distinct on a population basis, the patterns of pathogenic variants do overlap, indicating that the distinction between cyclic neutropenia and congenital neutropenia is primarily based on clinical findings and only secondarily on genotype [Dale et al, unpublished data]. <xref ref-type="bibr" rid="cyclic-n.REF.newburger.2010.314">Newburger et al [2010]</xref> identified individuals with the same pathogenic variant but different clinical phenotypes. </p>
          <p>Some <italic toggle="yes">ELANE</italic> pathogenic variants now appear to be exclusively or almost exclusively associated with cyclic neutropenia and no recognized risk of evolution to acute myelogenous leukemia (AML), whereas other pathogenic variants may possibly be associated with severe congenital neutropenia and increased risk of AML [<xref ref-type="bibr" rid="cyclic-n.REF.bellann_chantelot.2004.4119">Bellann&#x000e9;-Chantelot et al 2004</xref>].</p>
          <p>Analysis of the tertiary structure of neutrophil esterase suggested that pathogenic variants at the active site of the enzyme cause cyclic neutropenia, and pathogenic variants preventing normal folding and packaging of leukocyte elastase cause severe congenital neutropenia [<xref ref-type="bibr" rid="cyclic-n.REF.dale.2000.2317">Dale et al 2000</xref>, <xref ref-type="bibr" rid="cyclic-n.REF.k_llner.2006.493">K&#x000f6;llner et al 2006</xref>].</p>
        </sec>
        <sec id="cyclic-n.Penetrance">
          <title>Penetrance</title>
          <p>Penetrance in cyclic neutropenia is complete, but severity of manifestations varies among affected family members. Several families with three- and four-generation involvement have been described.</p>
        </sec>
        <sec id="cyclic-n.Anticipation">
          <title>Anticipation</title>
          <p>There is no clear evidence for anticipation in congenital or cyclic neutropenia. However, because a founder (i.e., the first known affected individual in a family) may be mosaic for an <italic toggle="yes">ELANE</italic> pathogenic variant and thus have a milder phenotype, his/her offspring may have more severe disease, giving the appearance of anticipation [<xref ref-type="bibr" rid="cyclic-n.REF.ancliff.2002.707">Ancliff et al 2002</xref>].</p>
        </sec>
        <sec id="cyclic-n.Nomenclature">
          <title>Nomenclature</title>
          <p>Originally described as an autosomal recessive disorder, Kostmann syndrome now appears to be genetically heterogeneous. Although the cause of Kostmann syndrome is largely unknown, a subset of individuals previously described as having Kostmann syndrome are now known to have heterozygous pathogenic variants in <italic toggle="yes">ELANE</italic> and, therefore, to be part of the spectrum of <italic toggle="yes">ELANE</italic>-related neutropenia [<xref ref-type="bibr" rid="cyclic-n.REF.zeidler.2002.82">Zeidler &#x00026; Welte 2002</xref>]. Of interest, one individual in the kindred originally described by Kostmann has an <italic toggle="yes">ELANE</italic> pathogenic variant [<xref ref-type="bibr" rid="cyclic-n.REF.carlsson.2006.589">Carlsson et al 2006</xref>].</p>
        </sec>
        <sec id="cyclic-n.Prevalence">
          <title>Prevalence</title>
          <p>Congenital neutropenia has an estimated frequency of 2:1,000,000-3:1,000,000 in the general population.</p>
          <p>Cyclic neutropenia has an estimated frequency of 1:1,000,000 in the general population, including both familial cases and simplex cases (i.e., single occurrences in a family).</p>
        </sec>
      </sec>
      <sec id="cyclic-n.Genetically_Related_Allelic_Dis">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No other phenotypes are known to be associated with mutation of <italic toggle="yes">ELANE</italic>.</p>
      </sec>
      <sec id="cyclic-n.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p><bold>Congenital neutropenia.</bold> The differential diagnosis of congenital neutropenia includes the following disorders:</p>
        <p>
          <bold>Isolated neutropenia</bold>
        </p>
        <list list-type="bullet">
          <list-item>
            <p>Kostmann syndrome, an autosomal recessive form of severe congenital neutropenia:</p>
            <list list-type="bullet">
              <list-item>
                <p><xref ref-type="bibr" rid="cyclic-n.REF.klein.2007.86">Klein et al [2007]</xref> identified homozygous pathogenic variants in <italic toggle="yes">HAX1</italic> (encoding HCLS1-associated protein X-1) in several individuals with Kostmann syndrome.Note: <italic toggle="yes">De novo</italic> heterozygous <italic toggle="yes">ELANE</italic> pathogenic variants (autosomal dominant severe congenital neutropenia) are much more common than <italic toggle="yes">HAX1</italic> pathogenic variants (autosomal recessive congenital neutropenia) as a cause of simplex cases of severe congenital neutropenia (i.e., a single occurrence in a family) [<xref ref-type="bibr" rid="cyclic-n.REF.xia.2009.535">Xia et al 2009</xref>]. For this reason, it is usually best to first sequence <italic toggle="yes">ELANE</italic> in seeking to determine the genetic basis for severe congenital neutropenia.</p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p>Mutation of <italic toggle="yes">G6PC3</italic> (encoding glucose-6-phosphate 3) results in an autosomal recessive form of severe congenital neutropenia [<xref ref-type="bibr" rid="cyclic-n.REF.klein.2011.399">Klein 2011</xref>]. See <related-object link-type="booklink" source-id="gene" document-id="g6pc3-def" document-type="chapter">G6PC3 Deficiency</related-object>.</p>
          </list-item>
          <list-item>
            <p>A pathogenic variant in <italic toggle="yes">GFI1</italic> (encoding zinc finger protein Gfi-1) has been reported in one person with severe congenital neutropenia [<xref ref-type="bibr" rid="cyclic-n.REF.person.2003.308">Person et al 2003</xref>].</p>
          </list-item>
          <list-item>
            <p>Benign familial neutropenia, an autosomal dominant form of congenital neutropenia with milder neutropenia and less severe symptoms</p>
          </list-item>
          <list-item>
            <p>Autoimmune neutropenia, usually attributed to anti-neutrophil antibodies</p>
          </list-item>
          <list-item>
            <p>Idiopathic neutropenia, isolated neutropenia of unknown cause</p>
          </list-item>
          <list-item>
            <p>Cyclic neutropenia</p>
          </list-item>
        </list>
        <p>
          <bold>Syndromes with congenital neutropenia</bold>
        </p>
        <list list-type="bullet">
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="gsd1" document-type="chapter">Glycogen storage disease type Ib</related-object>
            </p>
          </list-item>
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="sds" document-type="chapter">Shwachman-Diamond syndrome</related-object>
            </p>
          </list-item>
          <list-item>
            <p>Reticular dysgenesis</p>
          </list-item>
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="chh" document-type="chapter">Cartilage-hair hypoplasia</related-object>
            </p>
          </list-item>
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="chediak-higashi" document-type="chapter">Chediak-Higashi syndrome</related-object>
            </p>
          </list-item>
          <list-item>
            <p>Griscelli syndrome</p>
          </list-item>
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="barth" document-type="chapter">Barth syndrome</related-object>
            </p>
          </list-item>
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="was" document-type="chapter">Wiskott-Aldrich syndrome</related-object>
            </p>
          </list-item>
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="dkc" document-type="chapter">Dyskeratosis congenita</related-object>
            </p>
          </list-item>
          <list-item>
            <p>Myelokathexis (WHIM syndrome)</p>
          </list-item>
          <list-item>
            <p>Severe congenital neutropenia, autosomal recessive, 4 </p>
          </list-item>
        </list>
        <p><bold>Cyclic neutropenia.</bold> Other diagnoses confused with cyclic neutropenia include congenital neutropenia and idiopathic, autoimmune, and benign neutropenia of childhood.</p>
        <p><bold>Fever.</bold> Other disorders with recurrent fevers are <related-object link-type="booklink" source-id="gene" document-id="fmf" document-type="chapter">familial Mediterranean fever</related-object> and PFAPA (<italic toggle="yes">p</italic>eriodic <italic toggle="yes">f</italic>ever, <italic toggle="yes">a</italic>denopathy, <italic toggle="yes">p</italic>haryngitis, and <italic toggle="yes">a</italic>phthous ulcers).</p>
      </sec>
      <sec id="cyclic-n.Management_1">
        <title>Management</title>
        <sec id="cyclic-n.Evaluations_Following_Initial_D">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease in an individual diagnosed with <italic toggle="yes">ELANE</italic>-related neutropenia, the following are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Dental examination for gingival and periodontal disease</p>
            </list-item>
            <list-item>
              <p>Evaluation (particularly of those with severe congenital neutropenia) by an otolaryngologist and pulmonologist for chronic sinopulmonary inflammation and deep abscesses</p>
            </list-item>
            <list-item>
              <p>Evaluation of individuals with severe congenital neutropenia for evidence of myelodysplasia or leukemia</p>
            </list-item>
          </list>
        </sec>
        <sec id="cyclic-n.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Conventional management includes prompt treatment of fevers and infections with antibiotics.</p>
          <p>Individuals with abdominal pain require careful evaluation for the potentially lethal complications of peritonitis and bacteremia.</p>
        </sec>
        <sec id="cyclic-n.Prevention_of_Primary_Manifesta">
          <title>Prevention of Primary Manifestations</title>
          <p><bold>Granulocyte colony-stimulating factor (G-CSF).</bold> Treatment with granulocyte colony-stimulating factor (G-CSF) is effective in elevating blood neutrophil counts in both congenital neutropenia and cyclic neutropenia. G-CSF treatment ameliorates the symptoms and problems of infections in almost all affected individuals. (Although both G-CSF and GM-CSF have been used to treat <italic toggle="yes">ELANE</italic>-related neutropenia, G-CSF is much more effective and associated with fewer adverse effects than GM-CSF.)</p>
          <p>In cyclic neutropenia, G-CSF shortens the periods of neutropenia as well as the length of the neutropenic cycle. Treatment is known to be effective at least as early as age six months to one year. Studies indicate that treatment is effective with no adverse effects on growth, development, or pregnancy outcome with follow-up to age 18 years [<xref ref-type="bibr" rid="cyclic-n.REF.dale.2003.82">Dale et al 2003</xref>; Dale, unpublished observations].</p>
          <p>Treatment of cyclic neutropenia requires daily or alternate-day injections of G-CSF, normally in a dose of approximately 2 &#x000b5;g/kg/day. Individuals with congenital neutropenia often require higher doses (e.g., 5-10 &#x000b5;g/kg/day).</p>
          <p>Common side effects of G-CSF include bone pain and headache, splenomegaly, and osteoporosis. Vasculitis, rashes, arthralgias, and glomerulonephritis have been infrequently reported [<xref ref-type="bibr" rid="cyclic-n.REF.dale.2003.82">Dale et al 2003</xref>].</p>
          <p>
            <bold>Hematopoietic stem cell transplantation (HSCT)</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>For affected individuals with a well-matched donor, HSCT may be the preferred treatment option [<xref ref-type="bibr" rid="cyclic-n.REF.choi.2010.937">Choi &#x00026; Levine 2010</xref>, <xref ref-type="bibr" rid="cyclic-n.REF.oshima.2010.657">Oshima et al 2010</xref>].</p>
            </list-item>
            <list-item>
              <p>HSCT is the only alternative therapy for individuals with congenital neutropenia who are refractory to high-dose G-CSF or who undergo malignant transformation.</p>
            </list-item>
          </list>
        </sec>
        <sec id="cyclic-n.Prevention_of_Secondary_Complic">
          <title>Prevention of Secondary Complications</title>
          <p>Good dental hygiene with regular hygiene visits (several times per year) and careful brushing and flossing are recommended.</p>
        </sec>
        <sec id="cyclic-n.Surveillance">
          <title>Surveillance</title>
          <p>For those individuals with congenital neutropenia not undergoing HSCT, surveillance for evidence of malignant transformation to MDS/AML is critical to allow early therapeutic intervention. Observation should include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>General evaluations by parents and medical personnel several times a year</p>
            </list-item>
            <list-item>
              <p>Blood counts several times a year</p>
            </list-item>
            <list-item>
              <p>Annual bone marrow cytogenetic studies because of the frequent association of monosomy 7 and malignant transformation</p>
            </list-item>
          </list>
          <p>Note: Although sequencing of the receptor for G-CSF (G-CSF-R) from peripheral blood may also provide evidence of evolution to MDS/AML [<xref ref-type="bibr" rid="cyclic-n.REF.ancliff.2003a.685">Ancliff et al 2003a</xref>], its clinical utility is not yet clearly established [<xref ref-type="bibr" rid="cyclic-n.REF.freedman.2002.128">Freedman &#x00026; Alter 2002</xref>, <xref ref-type="bibr" rid="cyclic-n.REF.cassinat.2004.1553">Cassinat et al 2004</xref>, <xref ref-type="bibr" rid="cyclic-n.REF.beekman.2010.5131">Beekman &#x00026; Touw 2010</xref>]. </p>
        </sec>
        <sec id="cyclic-n.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>Evaluation of at-risk relatives can help identify those with mild or moderately severe disease who may benefit from treatment. If the family-specific <italic toggle="yes">ELANE</italic> pathogenic variant is known, molecular genetic testing can be used; otherwise serial ANCs can be evaluated. </p>
          <p>Note: Complete blood counts (CBCs) obtained weekly for a month until an ANC lower than 0.2 x 10<sup>9</sup>/L is documented in more than one sample confirms the diagnosis. A similar series of counts not showing neutropenia rules out this diagnosis.</p>
          <p>Treatment of these individuals with G-CSF or any other modality should be based on medical history and the severity of symptoms. It is not yet clear if there are specific risks (i.e., osteoporosis, myelodysplasia, or leukemia) associated with administering G-CSF to such individuals, but conservative management is recommended.</p>
          <p>See <xref ref-type="sec" rid="cyclic-n.Related_Genetic_Counseling_Issu">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes</p>
        </sec>
        <sec id="cyclic-n.Pregnancy_Management">
          <title>Pregnancy Management </title>
          <p>Pregnancies in women with severe chronic neutropenia are at substantial risk for miscarriage. </p>
          <p>A review of the records of 88 women (183 pregnancies) with congenital, cyclic, idiopathic or autoimmune neutropenia compared outcomes in those on G-CSF therapy during pregnancy with those not on G-CSF therapy during pregnancy [<xref ref-type="bibr" rid="cyclic-n.REF.boxer.2010">Boxer et al 2010</xref>]. In general the health of all the infants was equivalent for the two groups. Other findings included:</p>
          <list list-type="bullet">
            <list-item>
              <p>Reduced risk of fetal loss in the women treated during pregnancy. </p>
            </list-item>
            <list-item>
              <p>Eleven complications (one premature rupture of membranes, two life-threatening infections, two minor infections, and six premature labors) in 55 women (123 pregnancies) not treated with G-CSF during pregnancy. </p>
            </list-item>
            <list-item>
              <p>No life-threatening infections, no premature labors, five minor infections, and one patient who developed severe thrombocytopenia in 41 women (60 pregnancies) treated with G-CSF during pregnancy. </p>
            </list-item>
          </list>
        </sec>
        <sec id="cyclic-n.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Unrelated cord blood transplantation for neutropenia is being investigated; outcome appears to depend on the closeness of the match [<xref ref-type="bibr" rid="cyclic-n.REF.mino.2004.969">Mino et al 2004</xref>, <xref ref-type="bibr" rid="cyclic-n.REF.nakazawa.2004.287">Nakazawa et al 2004</xref>, <xref ref-type="bibr" rid="cyclic-n.REF.ferry.2005.45">Ferry et al 2005</xref>].</p>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions</p>
        </sec>
      </sec>
      <sec id="cyclic-n.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="cyclic-n.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p><italic toggle="yes">ELANE</italic>-related neutropenia is inherited in an autosomal dominant manner.</p>
        </sec>
        <sec id="cyclic-n.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Many individuals diagnosed with <italic toggle="yes">ELANE</italic>-related neutropenia have an affected parent.</p>
            </list-item>
            <list-item>
              <p>If neither parent is known to be affected, it is appropriate to evaluate both parents with complete blood counts (CBCs) obtained weekly for a month until an ANC lower than 0.2 x 10<sup>9</sup>/L is documented in more than one sample. Molecular genetic testing of both parents is appropriate if the pathogenic variant has been identified in the proband. </p>
            </list-item>
            <list-item>
              <p>Multiple cases have occurred via sperm donation from a single donor [<xref ref-type="bibr" rid="cyclic-n.REF.boxer.2006.633">Boxer et al 2006</xref>].</p>
            </list-item>
            <list-item>
              <p><italic toggle="yes">De novo</italic> mutations have been identified [<xref ref-type="bibr" rid="cyclic-n.REF.horwitz.1999.433">Horwitz et al 1999</xref>, <xref ref-type="bibr" rid="cyclic-n.REF.aprikyan.2002">Aprikyan et al 2002</xref>]; the frequency is unknown.</p>
            </list-item>
          </list>
          <p>Note: The family history may appear to be negative because of failure to diagnose the disorder in a mildly affected parent; for example, if the parent is the individual in whom mutation first occurred, s/he may have somatic mosaicism for the pathogenic variant and may be mildly/minimally affected.</p>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to sibs depends on the genetic status of the parents.</p>
            </list-item>
            <list-item>
              <p>If a parent of the proband is affected or has the pathogenic variant, the risk to sibs is 50%.</p>
            </list-item>
            <list-item>
              <p>When the parents are clinically unaffected, the risk to the sibs of a proband appears to be low; although no instances have been reported, germline mosaicism remains a possibility.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to evaluate the sibs of a proband with complete blood counts (CBCs) obtained weekly for a month until an ANC lower than 0.2 x 10<sup>9</sup>/L is documented in more than one sample. Molecular genetic testing of sibs is appropriate if the pathogenic variant has been identified in the proband.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with an <italic toggle="yes">ELANE</italic> pathogenic variant has a 50% chance of inheriting the variant.</p>
          <p>
            <bold>Other family members of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to other family members depends on the genetic status of the proband's parents.</p>
            </list-item>
            <list-item>
              <p>If a parent is affected, his or her family members are at risk.</p>
            </list-item>
          </list>
        </sec>
        <sec id="cyclic-n.Related_Genetic_Counseling_Issu">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="cyclic-n.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p><bold>Considerations in families with apparent <italic toggle="yes">de novo</italic> mutation.</bold> When neither parent of a proband with an autosomal dominant condition has the pathogenic variant or clinical evidence of the disorder, it is likely that the proband has a <italic toggle="yes">de novo</italic> mutation. However, possible non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy. </p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals. </p>
        </sec>
        <sec id="cyclic-n.Prenatal_Testing">
          <title>Prenatal Testing</title>
          <p>If the <italic toggle="yes">ELANE</italic> pathogenic variant has been identified in an affected family memver, prenatal diagnosis for pregnancies at increased risk may be available from a laboratory offering testing for this gene or custom preantal testing. </p>
          <p>Requests for prenatal testing for conditions which (like <italic toggle="yes">ELANE</italic>-related neutropenia) do not affect intellect and have some treatment available are not common. Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
          <p><bold>Preimplantation genetic diagnosis (PGD)</bold> may be an option for some families in which the pathogenic variant has been identified. </p>
        </sec>
      </sec>
      <sec id="cyclic-n.Resources">
        <title>Resources</title>
      </sec>
      <sec id="cyclic-n.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="cyclic-n.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>Leukocyte elastase, an enzyme synthesized in neutrophil precursors, is one of the first features of development of the neutrophil's primary granules. The enzyme is normally processed in the Golgi apparatus and packaged in the granules as the fully active enzyme. The cell is probably protected from the enzymatic activity of leukocyte elastase (neutrophil elastase) during synthesis by the terminal peptides that are cleaved just before packaging. It is currently presumed that, in congenital neutropenia and cyclic neutropenia, the abnormal enzyme is not inhibited or packaged normally and, therefore, damages the cells of the neutrophil series during their development. A natural experiment has provided compelling evidence that mutation of <italic toggle="yes">ELANE</italic> results in the destruction of neutrophils before they can enter circulation. The father of an individual with congenital neutropenia was found to be mosaic for the mutant <italic toggle="yes">ELANE</italic> allele; half of his somatic cells tested contained the mutant allele, but it was virtually absent in circulating neutrophils [<xref ref-type="bibr" rid="cyclic-n.REF.ancliff.2002.707">Ancliff et al 2002</xref>]. Cellular studies on pathogenesis of cyclic neutropenia have clearly demonstrated that accelerated apoptosis of neutrophil precursors is the proximate cause of the reduced neutrophil production [<xref ref-type="bibr" rid="cyclic-n.REF.aprikyan.2001.147">Aprikyan et al 2001</xref>]. The oscillation of blood counts in cyclic neutropenia is attributed to the excessive cell turnover in the early neutrophil compartments, coupled to a system of long-range regulation by feedback from peripheral tissues [<xref ref-type="bibr" rid="cyclic-n.REF.haurie.1998.2629">Haurie et al 1998</xref>]. The accelerated apoptosis may be mediated by altered expression of pro-apoptotic factors, Bcl-2, or cytoplasmic accumulation and induction of the unfolding protein response [<xref ref-type="bibr" rid="cyclic-n.REF.papadaki.2003.447">Papadaki &#x00026; Eliopoulos 2003</xref>, <xref ref-type="bibr" rid="cyclic-n.REF.carlsson.2004.3355">Carlsson et al 2004</xref>, <xref ref-type="bibr" rid="cyclic-n.REF.massullo.2005.3397">Massullo et al 2005</xref>, <xref ref-type="bibr" rid="cyclic-n.REF.k_llner.2006.493">K&#x000f6;llner et al 2006</xref>].</p>
          <p><italic toggle="yes">ELANE</italic>, which encodes leukocyte elastase (neutrophil elastase), is closely associated with the genes for other serine esterases, protease 3 and cathepsin G, also packaged in the neutrophil granule. Evidence to date indicates that these proximally located genes are normal in cyclic and congenital neutropenia.</p>
          <p><bold>Gene structure.</bold> The gene comprises five exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="cyclic-n" object-id="cyclic-n.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
          <p><bold>Pathogenic allelic variants.</bold>
<italic toggle="yes">ELANE</italic> pathogenic variants include missense and nonsense mutations, small deletions/insertions in exons, splicing defects, and changes in 5&#x02019; regulatory region. In one study, 104 of 125 individuals with congenital neutropenia had 18 different pathogenic variants and 94 of 105 probands with cyclic neutropenia were heterozygous for seven different pathogenic variants [<xref ref-type="bibr" rid="cyclic-n.REF.aprikyan.2002">Aprikyan et al 2002</xref>]. Other studies have generally reported a somewhat lower frequency, the variations probably depending on the pre-test identification and selection of cases.</p>
          <p><bold>Normal gene product.</bold> Leukocyte elastase (neutrophil elastase) is a 240-amino acid protein with broad proteolytic activities. It is synthesized, processed, and packaged in the granules of neutrophils during the differentiation of myeloblasts to promyelocytes [<xref ref-type="bibr" rid="cyclic-n.REF.garwicz.2005.38">Garwicz et al 2005</xref>].</p>
          <p><bold>Abnormal gene product.</bold> Three-dimensional structural analysis of leukocyte elastase (neutrophil elastase) based on the mutational patterns suggests that these mutations involve the binding site for this enzyme with its substrates.</p>
        </sec>
      </sec>
      <sec id="cyclic-n.References">
        <title>References</title>
        <sec id="cyclic-n.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="cyclic-n.Literature_Cited.reflist0">
            <ref id="cyclic-n.REF.ancliff.2003a.685">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ancliff</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gale</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liesner</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hann</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Linch</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <article-title>Long-term follow-up of granulocyte colony-stimulating factor receptor mutations in patients with severe congenital neutropenia: implications for leukaemogenesis and therapy.</article-title>
                <source>Br J Haematol</source>
                <year>2003a</year>
                <volume>120</volume>
                <fpage>685</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">12588357</pub-id>
              </element-citation>
            </ref>
            <ref id="cyclic-n.REF.ancliff.2003b.165">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ancliff</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gale</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Linch</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <article-title>Neutrophil elastase mutations in congenital neutropenia.</article-title>
                <source>Hematology.</source>
                <year>2003b</year>
                <volume>8</volume>
                <fpage>165</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">12745650</pub-id>
              </element-citation>
            </ref>
            <ref id="cyclic-n.REF.ancliff.2002.707">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ancliff</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gale</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watts</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liesner</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hann</surname>
                    <given-names>IM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strobel</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Linch</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Paternal mosaicism proves the pathogenic nature of mutations in neutrophil elastase in severe congenital neutropenia.</article-title>
                <source>Blood</source>
                <volume>100</volume>
                <fpage>707</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12091371</pub-id>
              </element-citation>
            </ref>
            <ref id="cyclic-n.REF.aprikyan.2001.147">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Aprikyan</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liles</surname>
                    <given-names>WC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodger</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jonas</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chi</surname>
                    <given-names>EY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dale</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Impaired survival of bone marrow hematopoietic progenitor cells in cyclic neutropenia.</article-title>
                <source>Blood</source>
                <volume>97</volume>
                <fpage>147</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">11133754</pub-id>
              </element-citation>
            </ref>
            <ref id="cyclic-n.REF.aprikyan.2002">
              <mixed-citation publication-type="book">Aprikyan AG, Stein S, Kutyavin T, Rodger E, Bolyard AA, Dale DC (2002) The causal role of mutations in the neutrophil elastase gene in cyclic and congenital neutropenia. Soc Exp Hematol (abstract)</mixed-citation>
            </ref>
            <ref id="cyclic-n.REF.barnes.2004.e757">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Barnes</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gerstle</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freedman</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carcao</surname>
                    <given-names>MD</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Clostridium septicum myonecrosis in congenital neutropenia.</article-title>
                <source>Pediatrics</source>
                <volume>114</volume>
                <fpage>e757</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">15574607</pub-id>
              </element-citation>
            </ref>
            <ref id="cyclic-n.REF.beekman.2010.5131">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Beekman</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Touw</surname>
                    <given-names>IP</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>G-CSF and its receptor in myeloid malignancy.</article-title>
                <source>Blood.</source>
                <volume>115</volume>
                <fpage>5131</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">20237318</pub-id>
              </element-citation>
            </ref>
            <ref id="cyclic-n.REF.bellann_chantelot.2004.4119">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bellann&#x000e9;-Chantelot</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clauin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leblanc</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cassinat</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodrigues-Lima</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beaufils</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vaury</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barkaoui</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fenneteau</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maier-Redelsperger</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chomienne</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donadieu</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Mutations in the ELA2 gene correlate with more severe expression of neutropenia: a study of 81 patients from the French Neutropenia Register.</article-title>
                <source>Blood</source>
                <volume>103</volume>
                <fpage>4119</fpage>
                <lpage>25</lpage>
                <pub-id pub-id-type="pmid">14962902</pub-id>
              </element-citation>
            </ref>
            <ref id="cyclic-n.REF.boxer.2010">
              <mixed-citation publication-type="webpage">Boxer LA, Bolyard AA, Marrero TM, Alter BP, Bonilla MA, Link D, Newburger P, Rosenberg PS, Shimamura A, Dale DC. Outcomes of pregnancies for women with severe chronic neutropenia with or without G-CSF treatment. Blood. 2010; 116:1490. Abstract available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://ash.confex.com/ash/2010/webprogram/Paper33438.html">online</ext-link>. Accessed 4-27-15.</mixed-citation>
            </ref>
            <ref id="cyclic-n.REF.boxer.2006.633">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Boxer</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stein</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buckley</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bolyard</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dale</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Strong evidence for autosomal dominant inheritance of severe congenital neutropenia associated with ELA2 mutations.</article-title>
                <source>J Pediatr</source>
                <volume>148</volume>
                <fpage>633</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">16737875</pub-id>
              </element-citation>
            </ref>
            <ref id="cyclic-n.REF.carlsson.2006.589">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Carlsson</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aprikyan</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ericson</surname>
                    <given-names>KG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stein</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Makaryan</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dale</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nordenskjold</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fadeel</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palmblad</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hentera</surname>
                    <given-names>JI</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Neutrophil elastase and granulocyte colony-stimulating factor receptor mutation analyses and leukemia evolution in severe congenital neutropenia patients belonging to the original Kostmann family in northern Sweden.</article-title>
                <source>Haematologica</source>
                <volume>91</volume>
                <fpage>589</fpage>
                <lpage>95</lpage>
                <pub-id pub-id-type="pmid">16670064</pub-id>
              </element-citation>
            </ref>
            <ref id="cyclic-n.REF.carlsson.2004.3355">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Carlsson</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aprikyan</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tehranchi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dale</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Porwit</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hellstrom-Lindberg</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palmblad</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Henter</surname>
                    <given-names>JI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fadeel</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Kostmann syndrome: severe congenital neutropenia associated with defective expression of Bcl-2, constitutive mitochondrial release of cytochrome c, and excessive apoptosis of myeloid progenitor cells.</article-title>
                <source>Blood</source>
                <volume>103</volume>
                <fpage>3355</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">14764541</pub-id>
              </element-citation>
            </ref>
            <ref id="cyclic-n.REF.cassinat.2004.1553">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cassinat</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bellann&#x000e9;-Chantelot</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Notz-Carrere</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Menot</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vaury</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Micheau</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bader-Meunier</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perel</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leblanc</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donadieu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chomienne</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Screening for G-CSF receptor mutations in patients with secondary myeloid or lymphoid transformation of severe congenital neutropenia. A report from the French neutropenia register.</article-title>
                <source>Leukemia</source>
                <volume>18</volume>
                <fpage>1553</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">15284863</pub-id>
              </element-citation>
            </ref>
            <ref id="cyclic-n.REF.choi.2010.937">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Choi</surname>
                    <given-names>SW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levine</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Indications for hematopoietic cell transplantation for children with severe congenital neutropenia.</article-title>
                <source>Pediatr Transplant.</source>
                <volume>14</volume>
                <fpage>937</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">20819181</pub-id>
              </element-citation>
            </ref>
            <ref id="cyclic-n.REF.dale.2001">
              <mixed-citation publication-type="book">Dale DC. Neutropenia and neutrophilia. In: Williams WJ, et al, eds. <italic toggle="yes">Hematology</italic>. 6 ed. New York, NY: McGraw-Hill; 2001:823-34.</mixed-citation>
            </ref>
            <ref id="cyclic-n.REF.dale.2003.82">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dale</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cottle</surname>
                    <given-names>TE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fier</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bolyard</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonilla</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boxer</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cham</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freedman</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kannourakis</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kinsey</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scarlata</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwinzer</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeidler</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Welte</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry.</article-title>
                <source>Am J Hematol</source>
                <volume>72</volume>
                <fpage>82</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">12555210</pub-id>
              </element-citation>
            </ref>
            <ref id="cyclic-n.REF.dale.2000.2317">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dale</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Person</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bolyard</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aprikyan</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bos</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonilla</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boxer</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kannourakis</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeidler</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Welte</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benson</surname>
                    <given-names>KF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horwitz</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia.</article-title>
                <source>Blood</source>
                <volume>96</volume>
                <fpage>2317</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">11001877</pub-id>
              </element-citation>
            </ref>
            <ref id="cyclic-n.REF.ferry.2005.45">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ferry</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ouach&#x000e9;e</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leblanc</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michel</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Notz-Carr&#x000e9;re</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tabrizi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flood</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lutz</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischer</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gluckman</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donadieu</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Hematopoietic stem cell transplantation in severe congenital neutropenia: experience of the French SCN register.</article-title>
                <source>Bone Marrow Transplant</source>
                <volume>35</volume>
                <fpage>45</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">15489867</pub-id>
              </element-citation>
            </ref>
            <ref id="cyclic-n.REF.freedman.2002.128">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Freedman</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alter</surname>
                    <given-names>BP</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Risk of myelodysplastic syndrome and acute myeloid leukemia in congenital neutropenias.</article-title>
                <source>Semin Hematol</source>
                <volume>39</volume>
                <fpage>128</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">11957196</pub-id>
              </element-citation>
            </ref>
            <ref id="cyclic-n.REF.garwicz.2005.38">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Garwicz</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lennartsson</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jacobsen</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gullberg</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindmark</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Biosynthetic profiles of neutrophil serine proteases in a human bone marrow-derived cellular myeloid differentiation model.</article-title>
                <source>Haematologica</source>
                <volume>90</volume>
                <fpage>38</fpage>
                <lpage>44</lpage>
                <pub-id pub-id-type="pmid">15642667</pub-id>
              </element-citation>
            </ref>
            <ref id="cyclic-n.REF.germeshausen.2010.1207">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Germeshausen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeidler</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stuhrmann</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lanciotti</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ballmaier</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Welte</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Digenic mutations in severe congenital neutropenia.</article-title>
                <source>Haematologica.</source>
                <volume>95</volume>
                <fpage>1207</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">20220065</pub-id>
              </element-citation>
            </ref>
            <ref id="cyclic-n.REF.haurie.1998.2629">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Haurie</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dale</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mackey</surname>
                    <given-names>MC</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Cyclical neutropenia and other periodic hematological disorders: a review of mechanisms and mathematical models.</article-title>
                <source>Blood</source>
                <volume>92</volume>
                <fpage>2629</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">9763544</pub-id>
              </element-citation>
            </ref>
            <ref id="cyclic-n.REF.horwitz.1999.433">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Horwitz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benson</surname>
                    <given-names>KF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Person</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aprikyan</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dale</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis.</article-title>
                <source>Nat Genet</source>
                <volume>23</volume>
                <fpage>433</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">10581030</pub-id>
              </element-citation>
            </ref>
            <ref id="cyclic-n.REF.klein.2007.86">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grudzien</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Appaswamy</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Germeshausen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sandrock</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schaffer</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rathinam</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boztug</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwinzer</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rezaei</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bohn</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Melin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carlsson</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fadeel</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dahl</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palmblad</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Henter</surname>
                    <given-names>JI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeidler</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grimbacher</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Welte</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease).</article-title>
                <source>Nat Genet</source>
                <volume>39</volume>
                <fpage>86</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">17187068</pub-id>
              </element-citation>
            </ref>
            <ref id="cyclic-n.REF.klein.2011.399">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Genetic defects in severe congenital neutropenia: emerging insights into life and death of human neutrophil granulocytes.</article-title>
                <source>Annu Rev Immunol.</source>
                <volume>29</volume>
                <fpage>399</fpage>
                <lpage>413</lpage>
                <pub-id pub-id-type="pmid">21219176</pub-id>
              </element-citation>
            </ref>
            <ref id="cyclic-n.REF.k_llner.2006.493">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>K&#x000f6;llner</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sodeik</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schreek</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heyn</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>von Neuhoff</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Germeshausen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeidler</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kruger</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schlegelberger</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Welte</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beger</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Mutations in neutrophil elastase causing congenital neutropenia lead to cytoplasmic protein accumulation and induction of the unfolded protein response.</article-title>
                <source>Blood</source>
                <volume>108</volume>
                <fpage>493</fpage>
                <lpage>500</lpage>
                <pub-id pub-id-type="pmid">16551967</pub-id>
              </element-citation>
            </ref>
            <ref id="cyclic-n.REF.massullo.2005.3397">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Massullo</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Druhan</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bunnell</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hunter</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marsh</surname>
                    <given-names>CB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Avalos</surname>
                    <given-names>BR</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Aberrant subcellular targeting of the G185R neutrophil elastase mutant associated with severe congenital neutropenia induces premature apoptosis of differentiating promyelocytes.</article-title>
                <source>Blood</source>
                <volume>105</volume>
                <fpage>3397</fpage>
                <lpage>404</lpage>
                <pub-id pub-id-type="pmid">15657182</pub-id>
              </element-citation>
            </ref>
            <ref id="cyclic-n.REF.mino.2004.969">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mino</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kobayashi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshida</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suzuki</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamada</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kobayashi</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Umbilical cord blood stem cell transplantation from unrelated HLA-matched donor in an infant with severe congenital neutropenia.</article-title>
                <source>Bone Marrow Transplant</source>
                <volume>33</volume>
                <fpage>969</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">15004540</pub-id>
              </element-citation>
            </ref>
            <ref id="cyclic-n.REF.nakazawa.2004.287">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nakazawa</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sakashita</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kinoshita</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saida</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shigemura</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yanagisawa</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shikama</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kamijo</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koike</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Successful unrelated cord blood transplantation using a reduced-intensity conditioning regimen in a 6-month-old infant with congenital neutropenia complicated by severe pneumonia.</article-title>
                <source>Int J Hematol</source>
                <volume>80</volume>
                <fpage>287</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">15540906</pub-id>
              </element-citation>
            </ref>
            <ref id="cyclic-n.REF.newburger.2010.314">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Newburger</surname>
                    <given-names>PE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pindyck</surname>
                    <given-names>TN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhu</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bolyard</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aprikyan</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dale</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>GD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boxer</surname>
                    <given-names>LA</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Cyclic neutropenia and severe congenital neutropenia in patients with a shared ELANE mutation and paternal haplotype: evidence for phenotype determination by modifying genes.</article-title>
                <source>Pediatr Blood Cancer.</source>
                <volume>55</volume>
                <fpage>314</fpage>
                <lpage>317</lpage>
                <pub-id pub-id-type="pmid">20582973</pub-id>
              </element-citation>
            </ref>
            <ref id="cyclic-n.REF.oshima.2010.657">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Oshima</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanada</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kobayashi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kato</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagatoshi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tabuchi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kato</surname>
                    <given-names>S</given-names>
                  </name>
                  <collab>Hematopoietic Stem Cell Transplantation Committee of the Japanese Society of Pediatric Hematology</collab>
                </person-group>
                <year>2010</year>
                <article-title>Hematopoietic stem cell transplantation in patients with severe congenital neutropenia: an analysis of 18 Japanese cases.</article-title>
                <source>Pediatr Transplant.</source>
                <volume>14</volume>
                <fpage>657</fpage>
                <lpage>663</lpage>
                <pub-id pub-id-type="pmid">20331518</pub-id>
              </element-citation>
            </ref>
            <ref id="cyclic-n.REF.palmer.1996.413">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Palmer</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stephens</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dale</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Genetics, phenotype, and natural history of autosomal dominant cyclic hematopoiesis.</article-title>
                <source>Am J Med Genet</source>
                <volume>66</volume>
                <fpage>413</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">8989458</pub-id>
              </element-citation>
            </ref>
            <ref id="cyclic-n.REF.papadaki.2003.447">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Papadaki</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eliopoulos</surname>
                    <given-names>GD</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>The role of apoptosis in the pathophysiology of chronic neutropenias associated with bone marrow failure.</article-title>
                <source>Cell Cycle</source>
                <volume>2</volume>
                <fpage>447</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">12963840</pub-id>
              </element-citation>
            </ref>
            <ref id="cyclic-n.REF.person.2003.308">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Person</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>FQ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duan</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benson</surname>
                    <given-names>KF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wechsler</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papadaki</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eliopoulos</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaufman</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertolone</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakamoto</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papayannopoulou</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grimes</surname>
                    <given-names>HL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horwitz</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2.</article-title>
                <source>Nat Genet</source>
                <volume>34</volume>
                <fpage>308</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">12778173</pub-id>
              </element-citation>
            </ref>
            <ref id="cyclic-n.REF.rosenberg.2006.4628">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rosenberg</surname>
                    <given-names>PS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alter</surname>
                    <given-names>BP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bolyard</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonilla</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boxer</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cham</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fier</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freedman</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kannourakis</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kinsey</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwinzer</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeidler</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Welte</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dale</surname>
                    <given-names>DC</given-names>
                  </name>
                  <collab>Severe Chronic Neutropenia International Registry</collab>
                </person-group>
                <year>2006</year>
                <article-title>The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy.</article-title>
                <source>Blood</source>
                <volume>107</volume>
                <fpage>4628</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">16497969</pub-id>
              </element-citation>
            </ref>
            <ref id="cyclic-n.REF.rosenberg.2008.210">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rosenberg</surname>
                    <given-names>PS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alter</surname>
                    <given-names>BP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Link</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stein</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodger</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bolyard</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aprikyan</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonilla</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dror</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kannourakis</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newburger</surname>
                    <given-names>PE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boxer</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dale</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Neutrophil elastase mutations and risk of leukaemia in severe congenital neutropenia.</article-title>
                <source>Br J Haematol</source>
                <volume>140</volume>
                <fpage>210</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">18028488</pub-id>
              </element-citation>
            </ref>
            <ref id="cyclic-n.REF.rosenberg.2010.196">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rosenberg</surname>
                    <given-names>PS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeidler</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bolyard</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alter</surname>
                    <given-names>BP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonilla</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boxer</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dror</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kinsey</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Link</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newburger</surname>
                    <given-names>PE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimamura</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Welte</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dale</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy.</article-title>
                <source>Br J Haematol.</source>
                <volume>150</volume>
                <fpage>196</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">20456363</pub-id>
              </element-citation>
            </ref>
            <ref id="cyclic-n.REF.xia.2009.535">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Xia</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bolyard</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodger</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stein</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aprikyan</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dale</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Link</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Prevalence of mutations in ELANE, GFI1, HAX1, SBDS, WAS and G6PC3 in patients with severe congenital neutropenia.</article-title>
                <source>Br J Haematol.</source>
                <volume>147</volume>
                <fpage>535</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">19775295</pub-id>
              </element-citation>
            </ref>
            <ref id="cyclic-n.REF.zeidler.2002.82">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zeidler</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Welte</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Kostmann syndrome and severe congenital neutropenia.</article-title>
                <source>Semin Hematol</source>
                <volume>39</volume>
                <fpage>82</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11957189</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="cyclic-n.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="cyclic-n.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>14 July 2011 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>7 July 2009 (cd) Revision: gene symbol <italic toggle="yes">ELA2</italic> replaced with <italic toggle="yes">ELANE</italic> - HGNC </p>
            </list-item>
            <list-item>
              <p>9 September 2008 (cg) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>4 January 2007 (cd) Revision: <italic toggle="yes">HAX1</italic> mutations identified in individuals with autosomal recessive severe congenital neutropenia (Kostmann disease)</p>
            </list-item>
            <list-item>
              <p>21 July 2006 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>13 September 2005 (dd) Revision: Genotype-Phenotype Correlations, Surveillance</p>
            </list-item>
            <list-item>
              <p>21 May 2004 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>1 October 2003 (cd) Revision: clinical testing availability</p>
            </list-item>
            <list-item>
              <p>17 June 2002 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>21 September 2001 (dd) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
